Procyon Advisors’s Elanco Animal Health ELAN Stock Holding History

Procyon Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12	Closed	–	–	429
2020 Q2	$0	Hold	12	–	–	﹤0.01%	1097
2020 Q1	$0	Buy	+12	New	+$329	﹤0.01%	1040

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Procyon Advisors's ELAN Position: Q3 2020 in Review

Procyon Advisors sold out of Elanco Animal Health (ELAN) in Q3 2020, closing a stake of 12 shares.

Procyon Advisors first reported a position in ELAN in Q1 2020 and held it in 2 quarters. The position peaked at $0 in Q2 2020. 360 funds tracked by Wall St. Rank hold ELAN as of Q3 2020.

Procyon Advisors reported no remaining Elanco Animal Health position as of Q3 2020 after selling out during the quarter.
Procyon Advisors sold 12 Elanco Animal Health shares in Q3 2020.
Procyon Advisors first reported a position in Elanco Animal Health in Q1 2020 and held it in 2 quarters.
Procyon Advisors's Elanco Animal Health position peaked at $0 in Q2 2020.
360 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.